Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Pieter H. van der Burgh"'
Autor:
Paula van Dommelen, Christina M. Leenders, Pieter H. van der Burgh, Aggie H.M.M. Balk, Kadir Caliskan, Ellen Klaassen, Wim Davidse
Publikováno v:
European Journal of Heart Failure, 10(11), 1136-1142. Wiley-Blackwell
European Journal of Heart Failure, 11, 10, 1136-1142
European Journal of Heart Failure, 11, 10, 1136-1142
Background: New strategies are required to optimize care in increasing numbers of chronic heart failure patients. The aim of this randomised trial was to evaluate a remote guidance system. Methods: Intervention group patients received a home TV-chann
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::821539552ff4debe2127f46ef81a122a
http://resolver.tudelft.nl/uuid:953aaa9e-cd09-4ecf-b4ff-3e8c7371d7eb
http://resolver.tudelft.nl/uuid:953aaa9e-cd09-4ecf-b4ff-3e8c7371d7eb
Autor:
Pieter H. van der Burgh, Michel A. Galjee, Wieger I. de Bruin, Salah A.M. Saïd, Jan van Es, Marc Hartmann, Clemens von Birgelen
Publikováno v:
Heart and vessels. 22(6)
We present the case of a 44-year-old woman with acute coronary syndrome and multiple coronary artery-left ventricular microfistulae at angiography. To evaluate the clinical significance of this observation and to obtain further insights into this rar
Autor:
Armand R.J. Girbes, Dirk J. van Veldhuisen, Balázs M. Szabó, Joost Kruik, Kong I. Lie, Pieter H. van der Burgh
Publikováno v:
Journal of Cardiac Failure, 2(3), 185-192. Churchill Livingstone
Szabó, B M, van Veldhuisen, D J, van der Burgh, P H, Kruik, J, Girbes, A R & Lie, K I 1996, ' Clinical and autonomic effects of ibopamine as adjunct to angiotensin-converting enzyme inhibitors in chronic heart failure. ', Journal of Cardiac Failure, vol. 2, no. 3, pp. 185-192 . https://doi.org/10.1016/S1071-9164(96)80040-6
Szabó, B M, van Veldhuisen, D J, van der Burgh, P H, Kruik, J, Girbes, A R & Lie, K I 1996, ' Clinical and autonomic effects of ibopamine as adjunct to angiotensin-converting enzyme inhibitors in chronic heart failure. ', Journal of Cardiac Failure, vol. 2, no. 3, pp. 185-192 . https://doi.org/10.1016/S1071-9164(96)80040-6
Background: The purpose of this study was to determine the additive value of ibopamine inheart failure patients who are treated with angiotensin-converting enzyme inhibitors. Ibopamine exerts hemodynamic and neurohumoral effects, and is beneficial in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8483ea1f29e0b6d42f5d3a4ccab68127
https://research.vumc.nl/en/publications/5b0b51f3-0d95-4e13-8aab-1269407ec71b
https://research.vumc.nl/en/publications/5b0b51f3-0d95-4e13-8aab-1269407ec71b
Publikováno v:
Journal of the American College of Cardiology. (2):417A
Multiple drug therapy, including ACE inhibitors, diuretics, vasodilators and digoxin is currently used to reduce signs and symptoms of chronic heart failure (CHF). Optimal treatment of these patients (pts) is a major clinical problem, as the prevalen